ClinicalTrials.gg
Active, not recruitingNCT05088746Updated Jul 7, 2026

Comparing Different Timings for Periodontal Re-evaluation After Non-surgical Periodontal Therapy (NSPT)

An observational study in Periodontitis and Periodontal Pocket, sponsored by University of Parma. Active, not recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.

Primary conditionPeriodontal PocketRegistry: PeriodontitisReclassifiedWhy we changed it
Registry
Periodontitis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Periodontal Pocket
Why
  1. The study's listed conditions name Periodontal Pocket, a narrower term within Periodontitis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Parma · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
52
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Periodontal Pocket with a site in Italy — 5 open to participants now, 6 under way, none of them phase 3. Periodontal Pocket · Italy.

Started
2021
with 2 others
Observational
3 of 20
none open now
Registered
6th of 20
by date

Among the 20 studies in Periodontal Pocket with a site in Italy, this one is one of 3 that started in 2021, is one of 3 observational ones, and was the 6th registered.

Periodontal Pocket

130 studies on the registry are indexed under Periodontal Pocket; 35 are open to participants now.

Browse Periodontal Pocket studies →

Open to participants now

5 of the 20 studies in Periodontal Pocket with a site in Italy are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 23 Periodontal Pocket studies recruiting now, 14 (61%) set no upper age limit and 4 (17%) stop at 75 or younger; 3 take children under 18; 10 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Periodontal Pocket with a site in Italy, or all of them as a file.
02

Study summary

This is a prospective cohort study that aims to describe the difference in terms of percentage of closed pockets (PPD \<5 mm and no BOP) when performing the periodontal re-evaluation at 3-4, 6-8 and 12 months.

Fifty-two, ≥18-year old, otherwise healthy, periodontitis patients will be recruited at Centro di Odontoiatria, Università di Parma.

Read the detailed description

This is a prospective cohort study describing the difference in terms of percentage of closed pockets (PPD \<5 mm and no BOP) when performing the periodontal re-evaluation at 3-4, 6-8 or 12 months. The trial will follow the recommendations of the Consolidated Standards of Reporting Trials (CONSORT) statement. The study consists of 7 visits over a period of 15 months.

Visit 1 - Baseline -

  • Informed consent, medical/dental history and demographics
  • Record concomitant medications and smoking history
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • Standardized peri-apical x-rays for the sites with PPD≥5mm, as per standard of practice (if not already available within the previous 6 months)
  • Intra-oral 3D scan
  • Oral hygiene instructions and demonstration of self-performed oral hygiene measures
  • PROMs questionnaires
  • Saliva collection and GCF collection from the deepest pockets (maximum of 5 sites)

Visit 2 and 3 - NSPT - (and extra visit 3.1 and 3.2 if needed) (within 60 days from baseline)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • NSPT, consisting in the careful removal of hard and soft deposits with ultrasonic instruments at infected sites performed by an experienced clinician following the principles of minimally invasive non-surgical therapy (MINST). A quadrant approach will be adopted and it will be left to the discretion of the clinician to choose whether to instrument 1 or 2 quadrants at a time and the length of session visits. Hence, 2 to 4 sessions of NSPT with an interval of 1 week between each other will be performed. During NSPT, teeth considered hopeless will be extracted as per standard of practice.
  • Reinforcement of oral hygiene instructions
  • PROMs questionnaires

Extra visits outside the study protocol may be arranged in case the patients need extractions or other dental treatments besides NSPT.

Visit 4 (4-6 weeks from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Visual inspection of signs of inflammation and plaque
  • Supragingival polish and reinforcement of oral hygiene instructions
  • PROMs questionnaires
  • Intra-oral 3D scan

Visit 5 (3-4 months from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • PROMs questionnaires
  • Intra-oral 3D scan
  • Saliva collection and GCF collection from the same sites identified at baseline
  • Supragingival polish and reinforcement of oral hygiene instructions

Visit 6 (6-8 months from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • PROMs questionnaires
  • Intra-oral 3D scan
  • Saliva collection and GCF collection from the same sites identified at baseline
  • Supragingival polish and reinforcement of oral hygiene instructions

Visit 7 (12 months ± 14 days from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • PROMs questionnaires
  • Intra-oral 3D scan
  • Standardized peri-apical x-rays
  • Saliva collection and GCF collection from the same sites identified at baseline
  • Supragingival polish and reinforcement of oral hygiene instructions

Photos and videos may be taken/recorded in any of the study visits for documentation purposes. The subject will not be identifiable from those photos/videos.

03

Conditions studied

  • Periodontitis
  • Periodontal Pocket

Browse trials for

04

In context

Periodontal Pocket Reclassified

130 studies on the registry are indexed under Periodontal Pocket; 35 are open to participants now.

This study's planned enrollment of 52 is close to the median of 51 across 16 observational studies indexed under Periodontal Pocket.

Browse Periodontal Pocket studies →

Lead sponsor

University of Parma is the lead sponsor of 77 studies on the registry; 8 are open to participants now.

Compared within Periodontal Pocket, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Periodontitis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients affected by periodontitis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Systemically healthy males and females ≥18 years old
  • Willingness to read and sign a copy of the Form after reading the Patient Information Sheet, and after the nature of the study has been fully explained
  • Clinical evidence of periodontitis, defined as the presence of interdental clinical attachment loss detectable at ≥2 non-adjacent teeth or buccal or oral clinical attachment loss ≥3mm with pocketing >3 mm detectable at ≥2 teeth (Tonetti et al., 2018)
  • Not having received subgingival instrumentation within the previous 12 months

Exclusion criteria

Exclusion Criteria:

  • Medical history that includes serious medical conditions or transmittable diseases (e.g. serious cardiovascular disease, organ transplant, renal failure, AIDS, viral etc.).
  • Antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
  • In treatment with drugs that induce gingival overgrowth
  • History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
  • History of alcohol or drug abuse.
  • Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results).
  • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
52 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Non-surgical periodontal therapy

    Procedure: Non-surgical periodontal therapy

Interventions

  • ProcedureNon-surgical periodontal therapy

    NSPT will be performed following the principles of minimally invasive non-surgical therapy (MINST) described by Nibali et al. (Nibali et al., 2015, Nibali et al., 2019)

07

What researchers measure

Primary outcomes

  1. changes in percentage of closed pockets (PPD <5 mm and no BOP)

    Time frame: From baseline to 3-4; 6-8 and 12 months

Secondary outcomes

  1. Changes in probing pocket depth (PPD), recession (REC) and clinical attachment level (CAL)

    Time frame: From baseline to 3-4; 6-8 and 12 months

  2. Changes in the percentages of sites with PPD reduction ≥2mm

    Time frame: From baseline to 3-4; 6-8 and 12 months

  3. Changes in the percentages of sites with CAL gain ≥2mm

    Time frame: From baseline to 3-4; 6-8 and 12 months

  4. Changes in the percentage of deep pockets (PPD≥6 mm)

    Time frame: From baseline to 3-4; 6-8 and 12 months

  5. Evaluation of global changes in quality of life

    In all post NSPT re-evaluations (Visit 4 to 7), a questionnaire (2 questions) will be given to participants to assess changes in quality of life following periodontal therapy

    Time frame: 4-6 weeks; 3-4 months; 6-8 months; 12 months

  6. changes in oral impact on daily performance (OIDP)

    Self-administered questionnaire, it is a composite measure of the impacts of oral health on the quality of life of people.

    Time frame: From baseline to 4-6 weeks; 3-4 months; 6-8 months; 12 months

  7. Changes in global ratings of periodontal health and quality of life

    self administered questionnaire and VAS scale

    Time frame: From baseline to 4-6 weeks; 3-4 months; 6-8 months; 12 months

  8. Evaluation of changes in patient perception about therapy

    VAS scale to evaluate patient perception about therapy

    Time frame: From non-surgical therapy visit to 4-6 weeks follow-up

08

Study locations

1 site
  • Centro Universitario di Odontoiatria
    Parma, Italy
09

References and documents

Individual participant data

Plan to share: No — Centro di Odontoiatria is the sponsor for this study. We will be using patient information in order to undertake this study and will act as the data controller for this study. This means that we are responsible for looking after patient information and using it properly. We will keep identifiable information for 20 years after the study has finished. The only people within the Centro di Odontoiatria who will have access to information that identifies the patients will be people who need to contact them about the research study, and make sure that relevant information about the study is recorded for their care, and to oversee the quality of the study or audit the data collection process. The people who analyse the information will not be able to identify patients and will not be able to find out their name or contact details.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2021 (actual). Primary completion is estimated for Dec 2026, 66 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2021
First posted
Oct 22, 2021
StartActual
Jun 1, 2021
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05088746
Lead sponsor
University of Parma
Responsible party
Prof Elena Calciolari (Principal Investigator. DDS, MS., PhD, University of Parma) — Principal investigator
First posted
Oct 22, 2021
Start date
Jun 1, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion